Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study

dc.authoridÖzdemir, Nesligül/0000-0003-2551-9549
dc.authoridAktas, Burak Yasin/0000-0001-5460-4895
dc.authoridUNAL, SERHAT/0000-0003-1184-4711
dc.authoridgülmez, ahmet/0000-0002-3353-344X
dc.authoridBayraktar-Ekincioglu, Aygin/0000-0002-3481-0074
dc.authoridInkaya, Ahmet Cagkan/0000-0001-7943-8715
dc.authorwosidÖzdemir, Nesligül/ABH-5503-2020
dc.authorwosidAktas, Burak Yasin/AAA-4726-2022
dc.authorwosidUNAL, SERHAT/I-9034-2013
dc.authorwosidgülmez, ahmet/ABI-8218-2020
dc.contributor.authorOzdemir, Nesligul
dc.contributor.authorAktas, Burak Y. Y.
dc.contributor.authorGulmez, Ahmet
dc.contributor.authorInkaya, Ahmet C. C.
dc.contributor.authorBayraktar-Ekincioglu, Aygin
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorUnal, Serhat
dc.date.accessioned2024-08-04T20:53:30Z
dc.date.available2024-08-04T20:53:30Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPurpose This study aimed to evaluate clinical pharmacist's contribution to the pneumococcal vaccination rate by providing education to cancer patients in hospital settings. Methods This study was conducted in 2 tertiary-care hospitals' medical oncology outpatient clinics. Patients over 18 years of age and diagnosed with cancer for less than 2 years, in remission stage, and have not previously received the pneumococcal vaccine were included. Patients were randomized to intervention and control groups. The intervention group was provided vaccination education and recommended to receive the PCV13 vaccine. The control group received routine care. Patients' knowledge about pneumonia/pneumococcal vaccine, Vaccine Attitude Examination Scale (VAX) score, and vaccination rates were evaluated at baseline and 3 months after the education. Results A total of 235 patients (intervention: 117, control: 118) were included. The mean age +/- SD was 57.86 +/- 11.88 years in the control and 60.68 +/- 11.18 years in the intervention groups. The numbers of correct answers about pneumonia/pneumococcal vaccine (p = 0.482) and VAX scores (p = 0.244) of the groups were similar at baseline. After the intervention, the median (IQR) number of correct answers in intervention group [10(3)] was higher than control group [8(4)] (p < 0.001). After the education, the total VAX score (mean +/- SD) was less in intervention group (33.09 +/- 7.018) than the control group (36.07 +/- 6.548) (p = 0.007). Three months after the education, 20.2% of the patients in the intervention and 6.1% in the control groups were vaccinated with pneumococcal vaccine (p = 0.003). Conclusions The pneumococcal vaccination rate in cancer patients has increased significantly by the education provided by a clinical pharmacist in hospital settings.en_US
dc.identifier.doi10.1007/s00520-023-07652-3
dc.identifier.issn0941-4355
dc.identifier.issn1433-7339
dc.identifier.issue3en_US
dc.identifier.pmid36856870en_US
dc.identifier.scopus2-s2.0-85149218904en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1007/s00520-023-07652-3
dc.identifier.urihttps://hdl.handle.net/11616/101202
dc.identifier.volume31en_US
dc.identifier.wosWOS:000941946200003en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofSupportive Care in Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCancer patientsen_US
dc.subjectClinical pharmacisten_US
dc.subjectPatient educationen_US
dc.subjectPneumococcal vaccineen_US
dc.subjectVaccination ratesen_US
dc.titleImpact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled studyen_US
dc.typeArticleen_US

Dosyalar